Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

non–small cell lung cancer

  • PD-L1 PET/CT Imaging with Radiolabeled Durvalumab in Patients with Advanced-Stage Non–Small Cell Lung Cancer
    You have access
    PD-L1 PET/CT Imaging with Radiolabeled Durvalumab in Patients with Advanced-Stage Non–Small Cell Lung Cancer
    Jasper Smit, Frank J. Borm, Anna-Larissa N. Niemeijer, Marc C. Huisman, Otto S. Hoekstra, Ronald Boellaard, Daniela E. Oprea-Lager, Danielle J. Vugts, Guus A.M.S. van Dongen, Berlinda J. de Wit-van der Veen, Erik Thunnissen, Egbert F. Smit and Adrianus J. de Langen
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 686-693; DOI: https://doi.org/10.2967/jnumed.121.262473
  • First-in-Humans Evaluation of a PD-L1–Binding Peptide PET Radiotracer in Non–Small Cell Lung Cancer Patients
    You have access
    First-in-Humans Evaluation of a PD-L1–Binding Peptide PET Radiotracer in Non–Small Cell Lung Cancer Patients
    Xin Zhou, Jinquan Jiang, Xue Yang, Teli Liu, Jin Ding, Sridhar Nimmagadda, Martin G. Pomper, Hua Zhu, Jun Zhao, Zhi Yang and Nan Li
    Journal of Nuclear Medicine April 1, 2022, 63 (4) 536-542; DOI: https://doi.org/10.2967/jnumed.121.262045
  • Response Evaluation and Survival Prediction After PD-1 Immunotherapy in Patients with Non–Small Cell Lung Cancer: Comparison of Assessment Methods
    You have access
    Response Evaluation and Survival Prediction After PD-1 Immunotherapy in Patients with Non–Small Cell Lung Cancer: Comparison of Assessment Methods
    Narjess Ayati, Sze Ting Lee, S. Rasoul Zakavi, Melissa Cheng, W.F. Eddie Lau, Sagun Parakh, Kunthi Pathmaraj and Andrew M. Scott
    Journal of Nuclear Medicine July 1, 2021, 62 (7) 926-933; DOI: https://doi.org/10.2967/jnumed.120.254508
  • You have access
    Hyperprogressive Disease in Patients with Non–Small Cell Lung Cancer Treated with Checkpoint Inhibitors: The Role of 18F-FDG PET/CT
    Angelo Castello, Sabrina Rossi, Emanuela Mazziotti, Luca Toschi and Egesta Lopci
    Journal of Nuclear Medicine June 1, 2020, 61 (6) 821-826; DOI: https://doi.org/10.2967/jnumed.119.237768
  • Open Access
    Early Phase I Study of a 99mTc-Labeled Anti–Programmed Death Ligand-1 (PD-L1) Single-Domain Antibody in SPECT/CT Assessment of PD-L1 Expression in Non–Small Cell Lung Cancer
    Yan Xing, Gitasha Chand, Changchun Liu, Gary J.R. Cook, Jim O’Doherty, Lingzhou Zhao, Nicholas C.L. Wong, Levente K. Meszaros, Hong Hoi Ting and Jinhua Zhao
    Journal of Nuclear Medicine September 1, 2019, 60 (9) 1213-1220; DOI: https://doi.org/10.2967/jnumed.118.224170
  • You have access
    Circulating Tumor DNA Reflects Tumor Metabolism Rather Than Tumor Burden in Chemotherapy-Naive Patients with Advanced Non–Small Cell Lung Cancer: 18F-FDG PET/CT Study
    Silvia Morbelli, Angela Alama, Giulia Ferrarazzo, Simona Coco, Carlo Genova, Erika Rijavec, Francesca Bongioanni, Federica Biello, Maria Giovanna Dal Bello, Giulia Barletta, Michela Massollo, Irene Vanni, Roberta Piva, Alberto Nieri, Matteo Bauckneht, Gianmario Sambuceti and Francesco Grossi
    Journal of Nuclear Medicine November 1, 2017, 58 (11) 1764-1769; DOI: https://doi.org/10.2967/jnumed.117.193201
  • You have access
    Comparison of Tumor Uptake Heterogeneity Characterization Between Static and Parametric 18F-FDG PET Images in Non–Small Cell Lung Cancer
    Florent Tixier, Dennis Vriens, Catherine Cheze-Le Rest, Mathieu Hatt, Jonathan A. Disselhorst, Wim J.G. Oyen, Lioe-Fee de Geus-Oei, Eric P. Visser and Dimitris Visvikis
    Journal of Nuclear Medicine July 1, 2016, 57 (7) 1033-1039; DOI: https://doi.org/10.2967/jnumed.115.166918
  • You have access
    Pretreatment 18F-FDG PET Textural Features in Locally Advanced Non–Small Cell Lung Cancer: Secondary Analysis of ACRIN 6668/RTOG 0235
    Nitin Ohri, Fenghai Duan, Bradley S. Snyder, Bo Wei, Mitchell Machtay, Abass Alavi, Barry A. Siegel, Douglas W. Johnson, Jeffrey D. Bradley, Albert DeNittis, Maria Werner-Wasik and Issam El Naqa
    Journal of Nuclear Medicine June 1, 2016, 57 (6) 842-848; DOI: https://doi.org/10.2967/jnumed.115.166934
  • You have access
    Multiparametric Analysis of the Relationship Between Tumor Hypoxia and Perfusion with 18F-Fluoroazomycin Arabinoside and 15O-H2O PET
    Ramsha Iqbal, Gem M. Kramer, Eline E. Verwer, Marc C. Huisman, Adrianus J. de Langen, Idris Bahce, Floris H.P. van Velden, Albert D. Windhorst, Adriaan A. Lammertsma, Otto S. Hoekstra and Ronald Boellaard
    Journal of Nuclear Medicine April 1, 2016, 57 (4) 530-535; DOI: https://doi.org/10.2967/jnumed.115.166579
  • You have access
    The Reverse Warburg Effect and 18F-FDG Uptake in Non–Small Cell Lung Cancer A549 in Mice: A Pilot Study
    Guojian Zhang, Jianbo Li, Xuemei Wang, Yuanyuan Ma, Xindao Yin, Feng Wang, Huaiyu Zheng, Xiaoxian Duan, Gregory C. Postel and Xiao-Feng Li
    Journal of Nuclear Medicine April 1, 2015, 56 (4) 607-612; DOI: https://doi.org/10.2967/jnumed.114.148254

Pages

  • Next
  • 1
  • 2
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire